|
C17ORF90 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.774290E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.639900E-04 |
| Normal-vs-Stage2 |
1.156590E-03 |
| Normal-vs-Stage3 |
3.618700E-03 |
| Normal-vs-Stage4 |
3.164100E-02 |
| Stage1-vs-Stage2 |
1.214180E-01 |
| Stage1-vs-Stage3 |
8.508800E-01 |
| Stage1-vs-Stage4 |
7.136600E-01 |
| Stage2-vs-Stage3 |
1.535000E-01 |
| Stage2-vs-Stage4 |
1.107190E-01 |
| Stage3-vs-Stage4 |
6.571200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.236400E-04 |
| Normal-vs-AfricanAmerican |
2.681200E-01 |
| Normal-vs-Asian |
1.994370E-02 |
| Caucasian-vs-AfricanAmerican |
3.013000E-01 |
| Caucasian-vs-Asian |
9.892600E-01 |
| AfricanAmerican-vs-Asian |
3.475800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.999340E-04 |
| Normal-vs-Female |
7.220800E-04 |
| Male-vs-Female |
2.117000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.661300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.563570E-03 |
| Normal-vs-Age(61-80Yrs) |
2.219600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.598500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.759400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.282800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.264800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.032600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.604000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.295000E-01 |
| Classical-VS-Follicular |
1.876000E-03 |
| Classical-VS-Other |
5.725200E-01 |
| Classical-VS-Normal |
2.657700E-03 |
| Tall-VS-Follicular |
1.283480E-03 |
| Tall-VS-Other |
2.519000E-01 |
| Tall-VS-Normal |
4.260800E-01 |
| Follicular-VS-Other |
5.688800E-01 |
| Follicular-VS-Normal |
1.60209999999772E-06 |
| Other-VS-Normal |
6.492100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.50049999997548E-06 |
| Normal-vs-N1 |
2.738900E-03 |
| N0-vs-N1 |
8.759600E-01 |
|
|
